| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 05/07/1997 | EP0771209A2 Novel peptides |
| 05/07/1997 | EP0771201A1 Methods of inhibiting primary endometrial hyperplasia |
| 05/07/1997 | EP0771198A1 Dihydro-2,3-benzodiazepine derivatives |
| 05/07/1997 | EP0771194A1 Use of droloxifene for the treatment of cardiovascular diseases |
| 05/07/1997 | EP0771192A1 Use of anti-vegf agents in the treatment of endometriosis |
| 05/07/1997 | EP0712398B1 Benzopyrans and pharmaceutical compositions containing them |
| 05/07/1997 | EP0663835B1 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy |
| 05/07/1997 | EP0566571B1 Diagnosis of metastatic cancer by the mts-1 gene |
| 05/07/1997 | CN1149288A Vitamin-D amide derivatives |
| 05/07/1997 | CN1149255A Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| 05/07/1997 | CN1149252A Novel substituted tryptamines, phenalkylamines and related compounds |
| 05/07/1997 | CN1149051A Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha1 adrenergic receptor antagonists |
| 05/07/1997 | CN1148982A Sikang Shennong Yangsheng Health-care pellet |
| 05/07/1997 | CN1148964A Tongniaoling for diuresis |
| 05/07/1997 | CA2189401A1 Purin-6-one derivatives |
| 05/06/1997 | US5627198 Blood metal concentrations |
| 05/06/1997 | US5627197 Piperidino- or piperazino-substituted oxazolidinone, thiazolidinones or imidazolidinones |
| 05/06/1997 | US5627182 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides |
| 05/06/1997 | US5627154 Calcium channel blocking polypeptides from Heteropoda venatoria |
| 05/06/1997 | US5626829 Anticarcinogenic agents with protractors and needle guides for imaging |
| 05/02/1997 | EP0770612A1 Terazosin crystalline polymorph and pharmaceutical compositions thereof |
| 05/02/1997 | EP0770395A1 Use of botulinum toxins for treating headache |
| 05/02/1997 | EP0770392A2 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in a pharmaceutical composition |
| 05/02/1997 | EP0770391A2 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in pharmaceutical compositions |
| 05/02/1997 | EP0770137A1 Improvements in production of proteins in host cells |
| 05/02/1997 | EP0770129A1 Zinc finger protein derivatives and methods therefor |
| 05/02/1997 | EP0769956A1 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens |
| 05/02/1997 | EP0769947A1 Indolinone compounds for the treatment of disease |
| 05/02/1997 | EP0769941A1 Use of droloxifene for the treatment of prostatic diseases, endometriosis and obesity |
| 05/01/1997 | WO1997015556A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands |
| 05/01/1997 | WO1997015318A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 05/01/1997 | WO1997015302A1 Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use |
| 05/01/1997 | WO1997015269A2 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 05/01/1997 | WO1996028154A3 Use of anti-oestrogens as male contraceptives |
| 05/01/1997 | CA2235756A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 05/01/1997 | CA2232336A1 Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use |
| 05/01/1997 | CA2205534A1 Method, compositions and kits for increasing the bioavailability of pharmaceutical agents |
| 04/30/1997 | CN1148807A Pyrimidine ortriazine carboxylic acid derivatives to be used as medicaments |
| 04/30/1997 | CN1148590A Sulfuryl or sulfinyl benzoyl guanidine derivative |
| 04/30/1997 | CN1148497A Medicine for treatment of renal lithiasis, liver and gall lithiasis |
| 04/29/1997 | US5624944 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[cd]indoles |
| 04/29/1997 | US5624923 Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
| 04/29/1997 | US5624670 Use of interleukin-8 for inducing cervical ripening |
| 04/28/1997 | CA2188901A1 Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases |
| 04/27/1997 | CA2188891A1 Use of lanthanide, manganese, tin, zinc or yttrium, cobalt, barium, strontium salt in pharmaceutical compositions |
| 04/24/1997 | WO1997014416A1 Conjugates useful in the treatment of benign prostatic hyperplasia |
| 04/24/1997 | WO1997009348A3 Orphan receptor |
| 04/23/1997 | EP0769023A1 Retinoic acid receptor epsilon |
| 04/23/1997 | EP0768878A1 Endothelin receptor antagonists |
| 04/23/1997 | CN1148340A Method for treating 5HT2B receptor related conditions |
| 04/22/1997 | US5622962 Prostate cancer, skin disorders, baldness |
| 04/22/1997 | US5622961 5α-reductase inhibitors |
| 04/22/1997 | US5622927 Mixture containing folic acid, panthenol and/or allantoin, protein hydrolysate, lactose or dextrose, lactic acid, magnesium sulfate, sodium or ammonium chloride, and a carrier; stability |
| 04/17/1997 | WO1997013844A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/17/1997 | WO1997013758A1 Pyridazinones as endothelin-receptor antagonists |
| 04/17/1997 | WO1997013513A1 At1-receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys |
| 04/17/1997 | WO1997013506A1 η-RAR ANTAGONIST LIGAND OR α-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 04/17/1997 | CA2599488A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/17/1997 | CA2207243A1 Endothelin receptor antagonists |
| 04/17/1997 | CA2187850A1 Physiologically active ei-1941 compounds |
| 04/16/1997 | EP0768306A1 Physiologically active hydrogenated benzopyran compounds |
| 04/16/1997 | EP0768305A1 N-Isoxazolyl-biphenylsulfonamide derivatives, their preparation and their use as endothelin antagonists |
| 04/16/1997 | EP0767801A1 Endothelin antagonists ii |
| 04/16/1997 | EP0767798A1 Sterol derivatives used for regulation of meiosis |
| 04/16/1997 | EP0767794A1 Phosphinic acid derivatives |
| 04/16/1997 | EP0767787A1 (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants |
| 04/16/1997 | EP0767773A1 Novel antitumor and antileukemia substances, preparation thereof and pharmaceutical compositions containing same |
| 04/16/1997 | EP0767660A1 Methods and formulations for modulating the human sexual response |
| 04/16/1997 | EP0767659A1 Transdermal administration of oxybutynin |
| 04/16/1997 | EP0609345A4 Biocompatible implant for the timing of ovulation in mares. |
| 04/16/1997 | EP0536282B1 Meducament for treating prostatic adenocarcinoma |
| 04/16/1997 | CN1147767A Use of serotonin antagonists (5HT3) for treating fibromyalgia |
| 04/16/1997 | CN1147512A Substituted 4H-pyrans |
| 04/16/1997 | CN1034569C Endothelin receptor antagonists |
| 04/15/1997 | US5621102 Reacting pinanediol chiral director and haloalkyl dialkoxy metalloid compound to undergo homologation reaction to form intermediate, reacting it with grignard reagent to form secondary alchol, acylating, coupling side chain |
| 04/15/1997 | US5620989 4-Arylmethyloxymethyl piperidines as tachykinin antagonsits |
| 04/15/1997 | US5620984 Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases |
| 04/15/1997 | US5620701 Methods of treatment using di-linoleoyl-mono-gamma-linolenyl glycerol |
| 04/12/1997 | CA2187576A1 Substituted biphenylsulfonamide endothelin antagonists |
| 04/10/1997 | WO1997012631A1 Drug for ameliorating renal function |
| 04/10/1997 | WO1997012624A1 Novel peptides |
| 04/10/1997 | WO1997012605A1 Controlled release matrix for pharmaceuticals |
| 04/10/1997 | DE19537548A1 Endothelin-Rezeptor-Antagonisten Endothelin receptor antagonists |
| 04/10/1997 | CA2233272A1 Novel peptides |
| 04/10/1997 | CA2207084A1 Controlled release matrix for pharmaceuticals |
| 04/09/1997 | EP0766684A1 Endothelin receptor antagonists |
| 04/09/1997 | CN1147251A Tetrasubstd. imidazole derivs., method for preparing same, resulting intermediates, use thereof as drug, and pharmaceutical composition contg. same |
| 04/08/1997 | US5618941 Benzenealkanoic acids for cardiovascular diseases |
| 04/08/1997 | US5618833 1-benzyl-1,3-dihydroindol-2-one derivatives, their preparation and the pharmaceutical compositions in which they are present |
| 04/08/1997 | US5618537 Plant-based medicaments for increasing the tone and modulating the tone of the smooth muscular organ |
| 04/03/1997 | WO1997011960A1 Antagonists of endothelin receptors |
| 04/03/1997 | WO1997011698A1 ALPHA 1b ADRENERGIC RECEPTOR ANTAGONISTS |
| 04/03/1997 | CA2232138A1 Alpha 1b adrenergic receptor antagonists |
| 04/02/1997 | EP0765867A1 Substituted benzoyl guanidines, process for their preparation, their use as antiarrhythmics or diagnostic agent as well as pharmaceuticals containing them |
| 04/02/1997 | EP0765668A1 Extract of Iridaceas and composition containing it |
| 04/02/1997 | EP0765661A2 Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis |
| 04/02/1997 | EP0765314A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 04/02/1997 | EP0655089A4 Effects of actin filaments on fibrin clot structure and lysis. |
| 04/02/1997 | CN1146765A Use of imidazole derivatives for treating disorders involving angiotensin receptors AT 1 and AT2, certain such products preparation thereof, use thereof as drugs, and pharmaceutical composition contai |
| 04/02/1997 | CN1146358A Shengkang injection solution (for nephrosis) and preparation technology |